The app Tät®III is developed for men undergoing radical prostatectomy due to cancer. Problems with stress urinary incontinence are common after such operation and pelvic floor exercises are recommended before and after surgery.
The app is available at App Store and at Google Play. The app was evaluated in a study that started in June, 2018.
In order to follow the use, there are questions integrated into the app regarding age, gender, education, residence (urban or rural), prostate operations, and urinary leakage. After one month there are follow-up questions regarding urinary leakage and exercises and it is possible to comment about the app. Three months after download follow-up questions regarding urinary leakage, exercises and the app are repeated.
Answering the questionnaires is voluntary, and entered data is anonymously transferred to the research database. The answers cannot be traced to a specific user or telephone number. The Ethics Review Board in Umeå has issued an advisory opinion, stating that they do not see any ethical problem with this study.
The Tät®III app builds upon the Tät® for women. The Tät®III app was developed by Eva Samuelsson with input from urologists and urotherapists in collaboration with the department ICT services and system development (ITS) at Umeå University.
Preliminary results were presented at the International Continence Society conference 2019, see abstract.
A scientific article was published in 2022. The study showed that the Tät®III app facilitated pelvic floor muscle training. The study included men who were soon to have surgery for prostate cancer and had downloaded the app. When the app was downloaded, 4 out of 10 men stated that they could do contractions “correctly” and 2 out of 10 trained every day. Of those who still used the app after three months, 9 out of 10 men stated that they could do the contractions “correctly” and 8 out of 10 trained every day. 97% stated that the app made the training simpler. The study included 388 men, and 137 (34%) of these responded to the three-months questionnaire. Read the article here
Copyright ©2024 eContinence AB, Tät®